Recognition of outstanding scientific work:

Kaisa Haglund receives the Jahre prize for young medical researchers

Kaisa Haglund
Kaisa Haglund

Kaisa Haglund from Harald Stenmark's group at the Institute for Cancer Research, Oslo University Hospital, and Centre for Cancer Biomedicine, University of Oslo is awarded the Anders Jahre's prize for young medical researchers for the year 2015 in recognition of her outstanding scientific work on cellular mechanisms regulating cell division and cancer development. Haglund shares the prize with Professor Pernilla Lagergren from Karolinska Institutet. The prize sum is NOK 400,000.

Anders Jahre's Awards for Medical Research honor research of outstanding quality in basic and clinical medicine. The prizes are awarded by the University of Oslo and are among the largest within Nordic biomedical research. The award ceremony will take place on the 15th of October.

Haglund receives the Jahre prize for her ground-breaking discoveries in basic cancer research. In particular she has used cell culture, mouse and fly models to explore novel mechanisms for downregulation of activated growth factor receptors and control of cytokinesis, the final step of cell division. Haglund has identified new mechanisms that regulate cytokinesis and shown that impairment of these mechanisms lead to tumourigenesis. Her findings are highly relevant to understanding the cellular control mechanisms that prevent normal cells from transforming into cancer cells.


Press release (in Norwegian) about the Anders Jahre award 2015 from the University of Oslo home page:
Jahreprisen til banebrytende forskere på cøliaki, leddgikt og kreft

Kaisa Haglund's project group: Cytokinesis in development and carcinogenesis

Harald Stenmark's group - Cellular membrane dynamics

Previous news articles about Haglund:

Article in PLOS Genetics: Molecular control of abscission in stem cells in vivo

Kaisa Haglund identifies novel regulator of cytokinesis

Kaisa Haglund awarded prestigious grant

42 scientists from Oslo University Hospital granted 69.2 mill NOK from the Norwegian Cancer Society